phosphoserine and luteolin

phosphoserine has been researched along with luteolin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huang, Q; Lu, J; Ong, CN; Ong, YB; Shen, HM; Shi, R; Zhao, B; Zhu, X	1

Other Studies

1 other study(ies) available for phosphoserine and luteolin

Article	Year
Luteolin sensitizes the anticancer effect of cisplatin via c-Jun NH2-terminal kinase-mediated p53 phosphorylation and stabilization. Molecular cancer therapeutics, 2007, Volume: 6, Issue:4 Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cisplatin; Drug Screening Assays, Antitumor; Female; Humans; JNK Mitogen-Activated Protein Kinases; Luteolin; Mice; Mice, Nude; Mitochondria; Phosphorylation; Phosphoserine; Phosphothreonine; Proteasome Endopeptidase Complex; Protein Transport; Thermodynamics; Tumor Suppressor Protein p53; Ubiquitin	2007

Article

Year

Luteolin sensitizes the anticancer effect of cisplatin via c-Jun NH2-terminal kinase-mediated p53 phosphorylation and stabilization.

Molecular cancer therapeutics, 2007, Volume: 6, Issue:4

Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cisplatin; Drug Screening Assays, Antitumor; Female; Humans; JNK Mitogen-Activated Protein Kinases; Luteolin; Mice; Mice, Nude; Mitochondria; Phosphorylation; Phosphoserine; Phosphothreonine; Proteasome Endopeptidase Complex; Protein Transport; Thermodynamics; Tumor Suppressor Protein p53; Ubiquitin

2007